The Subcellular Localization and Oligomerization 

Preferences of NME1/NME2 upon Radiation-Induced 

DNA Damage by Radić, Martina et al.
 International Journal of 
Molecular Sciences
Article
The Subcellular Localization and Oligomerization
Preferences of NME1/NME2 upon Radiation-Induced
DNA Damage
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Abstract: Nucleoside diphosphate kinases (NDPK/NME/Nm23) are enzymes composed of subunits
NME1/NDPK A and NME2/NDPK B, responsible for the maintenance of the cellular (d)NTP
pool and involved in other cellular processes, such as metastasis suppression and DNA damage
repair. Although eukaryotic NDPKs are active only as hexamers, it is unclear whether other NME
functions require the hexameric form, and how the isoenzyme composition varies in different cellular
compartments. To examine the effect of DNA damage on intracellular localization of NME1 and
NME2 and the composition of NME oligomers in the nucleus and the cytoplasm, we used live-cell
imaging and the FRET/FLIM technique. We showed that exogenous NME1 and NME2 proteins
co-localize in the cytoplasm of non-irradiated cells, and move simultaneously to the nucleus after
gamma irradiation. The FRET/FLIM experiments imply that, after DNA damage, there is a slight shift
in the homomer/heteromer balance between the nucleus and the cytoplasm. Collectively, our results
indicate that, after irradiation, NME1 and NME2 engage in mutual functions in the nucleus, possibly
performing specific functions in their homomeric states. Finally, we demonstrated that fluorophores
fused to the N-termini of NME polypeptides produce the largest FRET effect and thus recommend
this orientation for use in similar studies.
Keywords: NME; NDPK; Nm23; nucleoside diphosphate kinase; FRET; FLIM; live-cell imaging
1. Introduction
Nucleoside diphosphate kinases (NDPKs) are ubiquitous enzymes which catalyze the transfer
of the terminal phosphate group from (d)NTPs to (d)NDPs through a high-energy phosphohistidine
intermedier [1]. These enzymes are considered to be key players in the maintenance of the cellular NTP
pool. The NDPKs are encoded by NME/nm23 genes. Ten NME genes/proteins have been identified in
humans so far, but only NME1-NME4 proteins have a confirmed NDPK activity [2]. It is generally
accepted that eukaryotic NDPKs are active only in the form of hexamers, while the prokaryote enzymes
display a tetrameric structure [3]. In humans, at least 80% of the cytoplasmic NDPK activity is
being exerted by NME1/NDPK A and NME2/NDPK B, which combine to form a series of homo-
or heterohexameric isoenzymes (A6, A5B1, B6) [4]. NME1 and NME2 are highly homologous in
their nucleotide and amino acid sequence and possess the same gene and protein architecture. The
two genes are located in tandem on chromosome 17q21.3 (http://www.ncbi.nlm.nih.gov/Genbank)
and are highly homologous to their orthologs in rodents [5]. NME1 and NME2 separated through
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cis-duplication from a common ancestral gene after the emergence of amphibians and are considered
to be paralogs [6]. Both NME1 and NME2 possess the NDP kinase active site motif (NXXHG/ASD) and
are enzymatically active with similar kinetic parameters [7]. However, their polypeptide chains differ in
18 out of 152 amino acid residues, making NME1 an acidic and NME2 a basic protein. A huge interest
for these enzymes was raised in the early 1990s when it was suggested that the gene encoding NME1
was responsible for metastasis suppression in a murine melanoma model system [8]. In the years to
come, a number of studies reported that downregulation or loss of expression of NME1 was correlated
with the onset of metastasis and poor clinical outcome in many tumor types such as melanoma, breast
cancer, ovarian carcinoma, hepatocellular and laryngeal carcinoma, and several other malignancies [9].
Although not studied so extensively, NME2 was also shown to exhibit metastasis suppressor activity to
some extent [10]. However, in spite of intense research in this area, we still do not have a mechanistic
model of metastasis suppression activity of NME proteins.
Numerous studies reported that NME1 and NME2 participate in various major cellular processes
such as proliferation [11–13], apoptosis [14,15], differentiation and development [16–19], adhesion
and migration [20,21], and vesicular trafficking [22–24]. While the NDPK activity of NME1/NME2 is
well documented and mechanistically straightforward, both proteins have been appointed additional
biochemical activities, together or individually, which arose numerous still unanswered questions.
Histidine protein kinase activity has been assigned to both enzymes, but it was shown to target different
proteins. NME1 phosphorylates aldolase C [25], ATP citrate lyase [26], and kinase suppressor of Ras,
KSR (Kinase Suppressor of Ras), and this was hypothesized to be one of the major mechanisms of
NME1-mediated metastasis suppression [27]. NME2 phosphorylates the Gβ subunit of heterotrimeric
G-proteins on histidine 226 [28], and KCa3.1 potassium channel on histidine 358 [29]. A transcriptional
regulatory function has also been reported for both proteins: They both appear to repress the
transcriptional activity of PDGF promoter, while NME2 additionally plays the role of a transcription
factor for c-MYC oncogene [30], a finding that has been challenged by other authors [31]. Other
DNA-based activities of NME proteins include the 3′-5′exonuclease activity of NME1 that potentially
contributes to the regulation of metastatic potential [32], and the endonuclease activity of NME1 within
a macromolecular complex associated with the endoplasmic reticulum and targeted by Granzyme-A
during cytotoxic T lymphocyte-induced apoptosis [33]. Numerous studies reported NME1 and NME2
to be associated with a number of different binding/interacting partners [34]. Both proteins have
been found to interact with dynamin [24], while NME1 additionally interacts with PRUNE 1 (Prune
Exopolyphosphatase 1) [35], STRAP (Serine/Threonine Kinase Receptor Associated Protein) [36], MIF
(Macrophage Migration Inhibitory Factor) [37], VHL (Von Hippel–Lindau) tumor suppressor [38],
tumor virus-encoded oncoprotein EBNA 1-3C (Epstein-Barr Nuclear Antigen 1–3C) [39], and a
number of small GTPases [40]. NME2 was reported to interact with MDM2 (Mouse Double Minute
2 Homolog) [41], TRF1 (Telomeric Repeat Binding Factor 1) [42], ICAP1α (Integrin Cytoplasmic
Domain-Associated Protein 1α) [21], and several other proteins. NME1 and NME2 are ubiquitously
expressed, but the level of expression varies among different tissues and cell lines. Since it has been
reported that their promoter regions contain binding sites for distinct transcriptional factors, it is
presumed that the two paralogs might be regulated dissimilarly and in a cell-specific manner [43].
A large number of studies reported associations of either of the two proteins with diverse cellular
compartments and different cellular structures such as microtubules, the centrosome, the endoplasmic
reticulum, and the plasma membrane [44]. Most studies described cytoplasmic staining, especially
intense in the perinuclear region and diminishing towards the plasma membrane [45–48]. The
association of the NME/NDPKs with microtubules was proposed in 1984 by Nickerson and Wells [49].
Several groups confirmed a direct or indirect association of NME1 and/or NME2 with microtubules in
human and other model systems [45,50–53], but other studies failed to draw any connection between
NME proteins and the microtubuline network [47,54]. Further, Fan and coworkers reported NME1 to
be a constituent of the SET-complex (endoplasmic reticulum (ER)-associated DNA repair complex) [33].
It was also suggested that NME2 facilitates COPII (Coat Protein Complex II) assembly essential for
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the ER-Golgi trafficking [55]. The results of our group using GFP-fused NME1 and NME2 proteins
confirmed the co-localization of both proteins with the endoplasmic reticulum [46]. The association of
the NDPK with the translation apparatus was proposed by Sonnnemann and Mutzel [56]. A number of
authors demonstrated the association of NME proteins with intermediate filaments. For example, it was
reported that the NDPK co-purifies with vimentin from different tissues [57]. Roymans and coworkers
reported co-immunopreciptation of the rat ortholog of NME2 with vimentin in non-differentiated
cells, whereas, both NME1 and NME2 were found to be associated with GFAP (glial fibrillary acidic
protein), another intermediate filament protein [48]. Our group reported partial co-localization of
either of the two NME proteins with vimentin, similar to Pinon and coworkers [45,46]. NME1 and
NME2 have also been shown to localize at the plasma membrane. It was reported that ARF6-GTP
(ADP-Ribosylation Factor 6-GTP) interacts with NME1 and recruits it to the membrane where it
promotes dynamin activation [23]. NME2 was also found in this complex. The relatively recent studies
of Romani et al. [58] and Boissan et al. [24] confirmed the involvement of NME/NDPKs with dynamin
where the NDPK fuels dynamin with GTP and allows it to perform work with high thermodynamic
efficiency, therefore, placing a portion of the proteins within the membrane.
Several authors reported the presence of either of the two subunits in the nucleus during different
physiological processes [45,47,59]. Subramanian et al. and Murakami et al. [20,39] provided evidence
that NME1 directly interacts with Epstein–Barr virus nuclear antigens and this interaction directs
NME1 into the nucleus. Rayner and coworkers suggested that NME2 associates with ERβ (Estrogen
Receptor β) protein when estrogen stimulation directs NME2 into the nucleus of smooth muscle
cells [60]. Especially interesting are studies suggesting the participation of NME proteins in DNA
damage repair. The first evidence to support the involvement of NME1 in base excision repair (BER)
was observed in Saccharomyces cerevisiae, in which the yeast homolog of NME1, (YNK1), was shown
to contribute to error-prone repair of DNA induced by UV light and etoposide [61]. In addition,
NME1 was found to be overexpressed in a radiation dose-dependent manner together with APR1
(apurinic/apyrimidinic endonuclease-1), one of the crucial enzymes involved in BER. Using His
pull-down assay and co-immunoprecipitation, it was demonstrated that APE1 interacts with NME1,
suggesting the involvement of NME1 in BER in human pulmonary cancer cell line A549 [62]. Further,
Jarret and coworkers [63] reported the role of NME1 in nucleotide excision repair (NER). It has also
been demonstrated that NME1 participates in non-homologous end joining (NHEJ) of X-ray induced
double-stranded breaks (DSB) by affecting the cell-cycle checkpoint signaling, DNA repair, and the
MRN (a complex of three proteins, MRE11, RAD50 and NBS1 in humans, which functions as a major
recognition and stabilization complex within the DSB repair) [64]. The very recent work of Xue
and coworkers confirmed that NME1 primarily promotes NHEJ repair. They demonstrated that the
knock-down of NME1 significantly compromises the repair of irradiation induced double-stranded
breaks. NME1 localizes to sites of DNA damage while its downregulation impairs the recruitment
of ligase IV (LIG4) responsible for end DSB ligation [65]. Although numerous studies reported the
presence of both proteins mostly in the cytoplasm and occasionally in other compartments, the precise
timing and mechanism by which they change their localization is still elusive. Additionally, it is not
yet understood whether all potential NME functions require the hexameric form, and whether the
isoenzyme composition varies in different cellular events and compartments.
The goal of our study was to examine a possible change in the localization of NME1 and
NME2 proteins during 48 h after inducing DNA damage by live-cell imaging. Using FRET/FLIM,
a well-established and sensitive technique for studying molecular interactions, we additionally
examined the composition of NME1/NME2 oligomers in the nucleus and the cytoplasm in non-irradiated
and gamma-irradiated cells. All experiments were performed using exogenous, fluorescently labeled
NME proteins on irradiated and non-irradiated cells to determine the possible influence of gamma
irradiation on the association of NME proteins into homomers and heteromers, and their localization.
Our results reveal that NME1 and NME2 co-localize under all experimental conditions, both in
non-irradiated and irradiated cells, in the cytoplasm and in the nucleus. After gamma irradiation,
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a fraction of both proteins simultaneously translocated into the cell nucleus. FRET experiments
revealed a possible small shift of balance between the homomeric and heteromeric NME fractions after
inducing DNA damage.
2. Results and Discussion
2.1. NME1 and NME2 Translocate to the Nucleus after Gamma Irradiation Treatment
Our previous study of the subcellular localization of NME1 and NME2 proteins, using fluorescent
gene reporter system in order to specify their function and specific role in the cell, revealed that the
two proteins co-localize regardless of the cell type [46]. The proteins were principally localized in
the cytoplasm, but were also occasionally detected in the nucleus, especially in the late G1 phase.
In this study, we used time-lapse microscopy to assess the in vivo distribution of both NME1 and
NME2 proteins simultaneously, in non-irradiated and irradiated cells, in a 48-h period. For this
purpose, we co-transfected HeLa cells with plasmids carrying EGFP-NME1 and mCherry-NME2. The
non-irradiated cells were observed 24 h post-transfection during 48 h, while irradiated cells were
observed one hour post-irradiation and 25 h post-transfection during 48 h. Due to cell manipulation
after exposing the cells to gamma irradiation, it was impossible to observe irradiated cells immediately
after induction of DNA damage using live-cell imaging. Therefore, the first hour post-irradiation
was analyzed at fixed time points and on fixed cells transfected with plasmids carrying EGFP-NME1
and mCherry-NME2 using standard confocal microscopy. DNA damage was induced by subjecting
HeLa cells to gamma irradiation (Co-60) 24 h after transfection with the selected plasmids producing
fluorescently labeled proteins. The DNA damage was verified using Western blot analysis with the
γH2AX antibody, which recognizes phosphorylation of histone protein γH2AX on Ser139. H2AX
is phosphorylated at sites of double-stranded DNA breaks. Therefore, the upregulation of γH2AX
indicated that the DNA damage was successfully induced in HeLa cells (Supplementary Figure S1).
Figure 1 displays typical localization of the fluorescently labeled NME proteins during 15 h in
non-irradiated and irradiated cells using live-cell imaging. The results show that NME1 and NME2
co-localized and were present mostly in the cytoplasm of non-irradiated cells (Figure 1A). In irradiated
cells, already one hour after irradiation when the imaging commenced, a massive translocation of both
isoforms into the nuclei of the majority of cells could be seen (Figure 1B). Even 15 h post-irradiation,
the fluorescence was comparable in its intensity to the corresponding cytoplasmic compartments. The
enhanced nuclear staining of irradiated cells stayed visible in some cells even up to 24 h post-irradiation
(data not shown). After that period, the survival of irradiated and even non-irradiated cells decreased.
Importantly, EGFP-NME1 and mCherry-NME2 translocated to the nuclei simultaneously, which
might indicate that the assembled oligomers entered the nucleus intact. This is consistent with
the recent finding of a long-term stability of the purified NME1/NME2 hexamers [66]. Next, we
performed experiments on fixed cells at fixed time points (15, 30, 45 and 60 min post-irradiation), which
showed that the fluorescent NME proteins entered the nucleus already 30 min post-irradiation. The
quantification of relative fluorescence intensity revealed that the staining was significantly stronger in
the nuclei of irradiated cells compared to control, non-irradiated cells. This result substantiated our
observation in live cells that both NME proteins entered the nucleus after irradiation (Figure ??A–C).
The study of Jarett et al. [49] provided evidence that NME1 enters the nucleus of UV irradiated
793H1-FL8 cells several minutes post-induction while the nuclear signal reaches its maximum after one
hour where it remains for about 12 h. Although this finding is, in principal, consistent with ours, UVR
induces 6-4 photoproduct and other DNA-polymerase blocking lesions rather than double-stranded
breaks, and, therefore, activates a different repair mechanism (NER). Sheng and coworkers suggested
that NME1 enters the nucleus after DNA damage and possibly takes part in several DNA-repair
mechanisms [64]. It has even been suggested by Park and coworkers that the nuclear localization of
NME1 in head and neck squamous cell carcinoma could be associated with radiation resistance [67]
and, therefore, serve as a strong radiation resistance predictor. Similar research has been reported
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on human nasopharyngeal carcinoma [68] and oral squamous cell carcinoma [69]. The results of our
live-cell imaging experiments clearly showed that the two NME subunits are present mostly in the
cytoplasm of non-irradiated cells. After irradiation, both proteins enter the nucleus simultaneously.
While the presence of NME1 and NME2 in the nucleus has been thoroughly documented [42,47], their
simultaneous, although, possibly independent, entrance after DNA damage induction is quite puzzling.
Although the involvement of NME1 in several DNA repair mechanisms is fairly well established, there
has been very little evidence that NME2 participates in any of the DNA repair processes [70]. Taken
together, it remains unclear whether NME2 takes an active part in the repair of irradiation-induced
DNA damage.
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Figure 1. Time‐lapse live‐cell imaging showing subcellular localization of EGFP‐NME1 and mCherry‐
NME2 in HeLa cells. The cells were observed under confocal microscope one day after transfection. 
(A)  Non‐irradiated  cells.  (B)  Cells  that  were  exposed  to  gamma  irradiation  (Co‐60)  of  30  Gy 
approximately one hour before the time point 0 h. Scale bar, 20 μm. 
Figure 1 displays typical localization of the fluorescently labeled NME proteins during 15 h in 
non‐irradiated and irradiated cells using live‐cell imaging. The results show that NME1 and NME2 
Figure 1. Time-lapse live-cell imaging showing subcellular localization of EGFP-NME1 and
mCherry-NME2 in HeLa cells. The cells were observed under confocal microscope one day after
transfection. (A) Non-irradiated cells. (B) Cells that were exposed to gamma irradiation (Co-60) of
30 Gy approximately one hour before the time point 0 h. Scale bar, 20 µm.
Due to the cy otoxic effec s of transfection and irradiation treatments, we were unable to track
the potential return of the NME proteins into the cytoplasm in irradiated cells, but the return time
seems to be even 24 h in some cells, under our conditions (data not shown). It is well known that the
nuclear double membrane contains pore complexes which allow the transfer of ions, small molecules,
and small macromolecules in and out of the nucleus by simple diffusion. Most proteins, however, use
active transport to enter or exit the nucleus, a process that requires ATP and a nuclear localization
signal (NLS) or a nuclear export signal (NES) in their amino acid sequence. The NME proteins lack
NLS, which implies that they are transported into the nucleus by a carrier protein [71]. A demand for
an increased supply of the NME subunits into the nuclei of irradiated cell might appear plausible, since
the enzyme is required for synthesizing NTPs and dNTPs for DNA repair or possible transcription of
the necessary genes after DNA damage. This would justify the massive entrance of both proteins into
the nucleus upon irradiation that we have observed in our experiments. However, nucleotides can
easily enter the nucleus through the nuclear pore complexes, which makes the potential, energetically
demanding, transport of the NME proteins solely for that purpose less probable. It is possible that the
amplified NME1/2 signal in the nucleus of irradiated cells indicates another individual function of
the NME1 and/or NME2 induced by DNA damage. Local fueling of certain nuclear proteins with a
specific type of nucleotides is a valid possibility, since similar actions of the NME family members
have been described [24,72]. However, the massive, simultaneous movement of both NME proteins
into the nucleus favors the hypothesis that they are both engaged in the same function connected to
DNA damage repair.
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Figure 2. Localization of EGFP-NME1 and mCherry-NME2 in HeLa cells 24 h post-transfection in
non-irradiated cells and cells exposed to gamma irradiation (Co-60) of 30 Gy. (A) Then, 24 h after
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Scale bars, 20 µm. (B,C) Ratio of the fluorescence intensities of EGFP-NME1 (B) and mCherry-NME2
(C) in the cell nucleus and the cell cytoplasm is shown as median values and interquartile ranges. The
difference between relative fluorescence intensities in the nuclei of irradiated and non-irradiated cells is
statistically significant for periods of 30, 45, and 60 min. **: p ≤ 0.01.
2.2. Choosing the Optimal FRET Reporter Orientation for Estimating Fractional FRET Population of
Homomers and Heteromers
Förster resonance energy transfer (FRET) is a phenomenon that describes energy transfer through
nonradiative dipole–dipole coupling between a donor and an acceptor molecule in close proximity
(<10 nm) [73]. When a fluorescent donor experiences FRET, its bulk fluorescence intensity and the
lifetime of its excited state decrease. FRET can be used to monitor protein–protein interactions (PPIs)
in biological systems such as living cells, tissues, and organisms [74–76]. A widely used method
to measure FRET is fluorescence lifetime imaging microscopy (FLIM). In FRET-FLIM we measure
the donor’s excited state decay in the presence of an acceptor [77], i.e., estimate the change in the
donor’s lifetime induced by the acceptor. The main advantage of the FRET-FLIM method, compared to
traditional biochemical techniques for monitoring of PPIs, such as co-immunoprecipitation (co-IP), is
that it supports in vivo studies, is highly sensitive and specific, and can provide information on the
location of the interaction [78]. In this study, we used EGFP (the donor molecule) and mCherry (the
acceptor molecule) for labeling NME proteins. EGFP and mCherry represent a suitable FRET pair
due to a relatively long fluorescence lifetime of EGFP (2.4 ns), and a relatively large overlap between
donor’s emission and acceptor’s excitation spectra [79]. The FRET-FLIM method that we used in this
article estimated the fraction of fluorescent donor molecules in the sample that experience FRET. This
fraction of donor molecules that experienced FRET can be simplistically interpreted as a measure of
the fraction of EGFP-labeled NME proteins that reside in the same oligomer as mCherry-labeled NME
proteins. We designated this “fractional FRET population” by DF.
For FRET-FLIM measurements, mCherry was fused N-terminally with both NME1 and NME2
(mCherry-NME1 and mCherry-NME2), whereas EGFP was fused with both proteins either N-terminally
(EGFP-NME1 and EGFP-NME2) or C-terminally (NME1-EGFP and NME2-EGFP). It follows that
we can use two combinations of fusion proteins for estimating DF for either of the two homomers,
NME1/NME1 and NME2/NME2, and four combinations of fusion proteins for estimating DF for the
heteromer NME1/NME2. As the first step, we decided to determine which combination of fusion
proteins represents the best reporter for each oligomer, resulting in the largest DF. Namely, the relative
position of fluorophores with respect to the labeled proteins, being fused either to the N-terminus or
the C-terminus, can contribute differently to the overall FRET effect. The largest DF provides the largest
dynamic range for the detection of possible changes of DF induced by experimental manipulation.
DF was estimated for each of the 8 possible donor–acceptor combinations of fusion proteins based
on the FRET-FLIM measurements conducted using 18 cells from each group. The obtained results
showed that in all cases NME proteins with EGFP attached to their N-terminus exhibited the highest
fractional FRET population DF (Figure 3). The residual background DF was estimated using the control
sample, i.e., the cells expressing EGFP and mCherry alone, and amounted to approximately 0.05.
Although the C and the N termini in both NME proteins are positioned on the surface of the molecule
in close vicinity to each other, it was published that the C-terminus of a NME peptide stabilizes the
NDPK hexameric structure [80]. Fusing the fluorophore to the C-terminus of either of the two proteins
could, therefore, interfere with the stabilization of the hexameric structure and diminish the overall DF,
as observed (Figure 3). All the following experiments were, therefore, conducted with the fluorophores
fused to the N termini of NME proteins.
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proteins: NME1/NME2, NME1/NME1,  and NME2/NME2  (see main  text  for  explanation). Donor 
molecule (EGFP) was fused either to the N‐terminus or the C‐terminus of an NME protein, while the 
acceptor molecule (mCherry) was always fused to the N‐terminus of an NME protein. DF is shown as 
the median and the interquartile range. The star sign (*) indicates the highest DF for each of the three 
combinations of NME proteins. 
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Figure 3. Fractional FRET population (DF) for different combinations of fluorescently labeled NME
proteins: NME1/NME2, NME1/NME1, and NME2/NME2 (see main text for explanation). Donor
m l cule (EGFP) was fused either to the N-terminus or the C-t r inus of an NME prote n, while the
acceptor molecule (mCherry) was always fused to the N-t rminus of an NME protein. DF is shown as
the median and the interquartile r nge. The star sign (*) indicate the highest DF for each of the three
combinations of NME proteins.
Since the concentration of the exogenous proteins produced under a potent CMV promoter
exceeded by far the level of the endogenous proteins in a transfected cell [81–87], the participation
of endogenous proteins in the oligomer formation was considered negligible. Also, it is generally
accepted that NME proteins are present in the cell as hexamers. However, since we cannot exclude the
presence of other oligomeric forms under our experimental conditions, in this manuscript we are using
the terms oligomer, homomer, and heteromer rather than hexamer, homohexamer, and heterohexamer.
2.3. FRET/FLIM Experiments Indicate that DNA Damage Slightly Changes the Balance between the Oligomers
in Cellular Compartments
To assess the possible difference in the compartmentalization of different protei assemblies,
we compared the fractional FRET population, DF, between the nucleus and the cytoplasm in
non-irradiated and irradiated cells expressing one of the three pairs of fluorescently labeled proteins
(NME1/NME2, NME1/NME1, NME2/NME2). It was apparent that the DF was slightly larger in the
cytoplasm than in the nucleus in all of the NME protein combinations and under both conditions,
which indicates a systemic effect, probably on the FRET process itself. The cytoplasmic DF in the
case of the NME1/NME2 was statistically significantly larger than the corresponding nuclear DF in
non-irradiated cells (Figure 4A). The statistical significance of this difference was lost after irradiation,
but we noted an increased variation of DF in irradiated cells (Figure 4B). On the contrary, the difference
between the cytoplasmic and the nuclear DF was not statistically significant in non-irradiated cells
expressing either of the labeled homomers, NME1/NME1 and NME2/NME2, but it became statistically
significant after irradiation (Figure 4C–F).
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On the basis of the statistical significance alone, one could argue that in the irradiated cells the
balance during the NME oligomer assembly or relocation shifts sli htly in favor of homomers in t e
cytoplasm and heteromers in the nucleus. This phenomenon can be a result of a selective translocation
of specific NME oligomers after irradiation, but it can als indicate e hanced re-assembly of NME
heteromers in the nucleus. However, no statistically significant differe ce was determined when DF
values were compared between non-irradiated and irradiated cellular compartments for any particul r
oligo er (Suppl mentary Figure S2). As already m ntioned, NME proteins in eukaryotes exert their
NDPK function only in the form f hexamers. Gilles and coworkers obtained results that favor the
hypothesis that NDP kinases form isoenzymes by random associati n of the two subunits, NME1 and
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NME2 [4]. Using native mass spectrometry, Potel et al. showed that purified endogenous NME1 and
NME2 oligomerize following the statistical rule and, therefore, form primarily heterohexamers [66].
The distribution and abundance of different hexamers follows the hypergeometrical distribution,
indicating that the probability of incorporation into an oligomer is equal for NME1 and NME2. In the
case of the equal number of both protein species, both possible homohexameric assemblies, NME16
and NME26, are present in marginal proportions, representing less than 2% of the total hexameric
population. A higher abundance of either of the homohexamers can thus occur solely as a consequence
of a higher stoichiometry of one or the other isoform and is directly dependent on their relative
transcription levels. The observed slight changes in the relative DF between the nucleus and the
cytoplasm upon gamma irradiation might indicate a shift in the relative abundance of the two isoforms
or a change in their interaction kinetics. Either effect would increase the fraction of homomers in one
of the cell compartments.
It could be speculated that the balance of the homomeric versus heteromeric populations between
cellular compartments is more important than their absolute levels. The difference in the balance could
support the theory that in certain cases, in this case DNA damage, a fraction of NME1 and NME2
execute some discrete, diverse functions in the homomeric state. Since this shift in balance was not
large, we presumed that the fraction of the NME1 or NME2 proteins engaged in any other function,
other than the NDPK nucleotide supply function, after DNA damage is rather small. A simplified
schematic representation of the results obtained by FRET/FLIM experiments can be seen in Figure 5.
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In  order  to  independently  corroborate  protein–protein  interactions  obtained  by  FRET/FLIM 
experiments, we performed co‐immunoprecipitation of NME1 and NME2 proteins from the nuclear 
and the cytosolic fraction after cell fractionation. For that purpose, we co‐transfected the cells with 
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experiments with anti‐FLAG M2 agarose separately on nuclear and cytosolic fractions. Our results 
Figure 5. Schematic interpretation of the changes in DF determined by FRET/FLIM experiments and
shown in Figure 4. (A) Before irradiation, DF for fluorescently labelled NME1 and NME2 is significantly
larger in the cytoplasm than in the nucleus, indicating more NME1/NME2 heteromers in the cytoplasm
than in the nucleus. After irradiation, this difference is rendered insignificant. This panel corresponds to
Figure 4A,B. (B) Before irradiation, DF for fluorescently labelled NME1 is not distinguishable between
the cytoplasm and the nucleus. After irradiation, DF becomes significantly larger in the cytoplasm than
in the nucleus, indicating more NME1 homomers in the cytoplasm than in the nucleus. This panel
corresponds to Figure 4C,D. An equivalent interpretation applies to Figure 4E,F, corresponding to
oligomerization of NME2. Oligomerization state of NME proteins is simplistically shown as being
either dimeric or monomeric, whereas in reality different hexameric configurations probably dominate.
In both panels, the differences between the cytoplasm and the nucleus are exaggerated for clarity.
In order to independently corroborate protein–protein interactions obtained by FRET/FLIM
experiments, we p rformed co-immunoprecipitation of NME1 and NME2 prot ins from the nuclear
and the cytosolic fraction after cell fractiona ion. F r that purpose, we co-transfected cells with
NME1-FLAG (FLAG - short octapeptide tag) a d NME2 protein and p rf rmed pull- own experiments
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with anti-FLAG M2 agarose separately on nuclear and cytosolic fractions. Our results showed high
expression levels of both proteins in the cytosolic fraction and lower expression levels of both proteins
in the nuclear fraction (Supplementary Figure S3). We were able to detect the interaction of exogenous
NME1-FLAG and NME2 proteins in both fractions, even though it was substantially weaker in the
nuclear fraction. Our results indicate that the use of FRET/FLIM method for comparing the extent
of protein–protein interactions in different cellular compartments is more robust, with respect to the
variations of protein expression levels between the compartments, than co-immunoprecipitation.
Lastly, this is the first study that uses the FRET/FLIM method to assess the oligomerization
properties of the two NDPK/NME protein subunits. We showed that fluorophores fused to the
N-termini of both NME polypeptides produce the largest FRET effect upon their interaction and,
therefore, should be used for similar studies.
3. Materials and Methods
3.1. Cell Lines
HeLa (ATCC® CCL-2™) cells were grown in DMEM (Dulbecco’s Modified Eagle Medium) (Gibco,
Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (Thermo
Fisher Scientific, Waltham, MA, USA), 1% streptomycin-penicillin (Sigma Aldrich, St. Louis, MO,
USA), 1 mM sodium pyruvate (Life Technologies, Carlsbad, CA, USA) and 2 mM L-glutamine (Sigma
Aldrich, St. Louis, MO, USA). Cells were maintained in a humidified chamber at 37 ◦C under 5% CO2
atmosphere. HeLa cell line was tested mycoplasma-free.
3.2. Plasmids
The pEGFPN1-NME1 and pEGFPN1-NME2 were obtained courtesy of Dr. Marie-Lise Lacombe
(French Institute of Health and Medical Research, Centre de Recherche St Antoine, U938, Paris,
France). The pcDNA3-NME1-FLAG was obtained as described before [88]. The pEGFPC1-NME1
and pEGFPC1-NME2 vectors were constructed by subcloning from pcDNA3 vectors containing
cDNAs from either of the two genes (obtained courtesy of Dr. Marie-Lise Lacombe, French
Institute of Health and Medical Research, Centre de Recherche St Antoine, U938, Paris, France) into
pEGFPC1 vector (Clontech, Kyoto, Japan). In brief, the pcDNA3-NME vectors were digested with
EcoRI/XhoI and ligated with EcoRI and Sal I sites into pEGFPC1 expression vector. For cloning into
pmCherry, the PCR-generated cDNA for NME1(5’GTCTAGCTCGAGTAATGGCCAACTGTGAGCG
3′ and 5′ CTAGACGAATTCTCATCATTCATAGATCC 3′) and
NME2 (5’GTCTAGCTCGAGTAATGGCCAACCTGGAGC 3′ and 5′
CTAGACGAATTCTTATTATTCATATACCCAGTCATGAGC 3′) were digested with XhoI and
EcoRI and ligated with XhoI/EcoRI sites of pmCherryC1 expression vector. The NME1 and NME2
fragments were amplified using EmeraldAmp MAX PCR Master Mix (Clontech, Kyoto, Japan).
Plasmid constructs were verified by sequencing (ABI PRISM 3100-Avant Genetic Analyzer, Applied
Biosystems, Foster City, CA, USA) using ABI PRISM BigDye Terminator v.3.1 Ready Reaction Cycle
Sequencing Kit (Applied Biosystems, Foster City, CA, USA).
3.3. Transfection
For FRET-FLIM analysis and live-cell imaging, 105 cells/well were seeded 24 h prior to
transfection in a four-chamber glass-bottom dish (Cellvis, Mountain View, CA, USA). For fixed
samples, 5.5 × 104 cells were seeded in an 8-well chamber slide (Ibidi, Gräfelfing, Germany). For
co-immunoprecipitation experiments, 2 × 106 cells were seeded in 100-mm Petri dishes (BD Biosciences,
Franklin Lakes, NJ, USA). About 90% confluent HeLa cells were transfected using Lipofectamine 2000
(Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA) transfection reagent with 1.25 µg, 1.5 µg,
and 12 µg of total plasmid DNA, respectively, according to manufacturer’s protocol. For co-transfection
experiments, two plasmids in 1:1 ratio were used but with the equal total amount of DNA.
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3.4. DNA Damage
DNA damage was induced by gamma ray emitter cobalt-60 (Co-60). Twenty-four hours
post-transfection, the cells were irradiated either with 15 Gy (for FRET/FLIM analysis) by dose
rate of 2 Gy/min or with 30 Gy (for confocal imaging and co-immunoprecipitation experiments)
by dose rate of 4 Gy/min. The media was changed immediately after irradiation and the cells
subjected to confocal imaging or protein isolation. For Western blot analysis after irradiation, the
cells were harvested from a 100-mm Petri dishes (BD Biosciences, Franklin Lakes, NJ, USA). The
non-irradiated and irradiated cells were collected by washing with PBS and scraping. Irradiated cells
were collected 24 h after irradiation. Proteins were extracted in Dulbecco’s phosphate buffer saline
(DPBS) (Sigma Aldrich, St. Louis, MO, USA) completed with protease inhibitors (complete, mini,
EDTA (ethylenediaminetetraacetic acid)-free; Roche Diagnostics, Basel, Switzerland). Pellets were
sonicated (1 mm probe, 2 × 10 sec). Protein concentration was determined by the Pierce BCA Protein
Assay Kit (Pierce, Thermo Fisher Scientific, Waltham, MA, USA).
3.5. Co-immunoprecipitation
Co-immunoprecipitation experiments were done on the nuclear and the cytosolic fraction after
transfection and induction of DNA damage. Nuclear and cytoplasmic proteins were extracted using
Nuclear Extract Kit (Abcam, Cambridge, UK, ab221978) according to manufacturer’s protocol. Protein
concentration was determined by Pierce BCA Protein Assay Kit (Pierce, Thermo Fisher Scientific,
Waltham, MA, USA). Co-immunoprecipitation was performed using ANTI-FLAG® M2 Agarose
Affinity Gel (Sigma, Munich, Germany). Agarose beads were pre-equilibrated by washing with TENN
buffer (50 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% NP-40 (v/v)) three times. The amount of
100 µg of total proteins was transferred in tube with pre-equilibrated beads and it was incubated over
night at 4 ◦C on a rocking platform. Total cell lysate of non-transfected cells was used as a control for
immunoprecipitation (CTRL). The next day, beads were washed with PBS and PBS/0.05% Tween-20.
Amount of 20 µg of total proteins was used as input for nuclear and cytosolic fraction (INP N and INP
C). Proteins were denatured and loaded onto 12% SDS-polyacrylamide gel.
3.6. Western Blot Analysis
Proteins were separated on 12% SDS-polyacrylamide gel (co-immunoprecipitation) and 15%
SDS-polyacrylamide gel (DNA damage) and transferred to a nitrocellulose membrane (Merck Millipore,
Burlington, MA, USA). The antibodies used in this study were as follows: Primary mouse anti-NME2
(Kamiya Biomedical, Tukwila, WA, USA, KM1121, 1:1000), primary mouse anti-FLAG (Sigma Aldrich,
St. Louis, MO, USA, SLBN5629V, 1:500), primary rabbit anti-histone H3 (Abcam, Cambridge,
UK, ab1791, 1:1000), primary mouse anti-GAPDH (from apoptosis WB antibody cocktail, Abcam,
Cambridge, UK, ab110415, 1:500), primary rabbit anti-γH2AX (Abcam, Cambridge, UK, ab11174
1:2000), primary mouse anti-β-actin (Proteintech, Rosemont, IL, USA, 60008-1-1g, 1:3000), secondary
HRP (horseradish peroxidase)-conjugated anti-rabbit (Cell signaling, Danvers, MA, USA, 1:3000) and
secondary HRP-conjugated anti-mouse (GE Healthcare, London, UK, 1:3000). Proteins were visualized
using Western Lightning Chemiluminescence Reagent Plus (Perkin Elmer, Waltham, MA, USA) on
Alliance 4.7 imaging system (UVItec, Cambridge, UK).
3.7. Confocal Imaging of Live and Fixed Cells
Confocal microscopy was performed using Leica TCS SP8 X FLIM microscope equipped with a
HC PL APO CS2 63×/1.40 oil objective, 405-nm diode laser, and a supercontinuum excitation laser
(Leica Microsystems, Wetzlar, Germany). Stage-top environmental control system was used for
time-lapse live-cell imaging to maintain temperature at 37 ◦C and Leibovitz’s L-15 medium (Thermo
Fisher Scientific, Waltham, MA, USA) was used to support cell growth in the environment without
CO2 equilibration.
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For analysis of the first hour post-irradiation, 24-h post-transfection cells were washed three times
in phosphate-buffered saline (PBS), fixed in 2% paraformaldehyde (PFA) for 15 min and washed three
times in PBS. After fixation, cells were mounted in mounting medium (DAKO, Glostrup, Denmark)
supplemented with 1 µg/mL 4′,6-diamidino-2-phenylindole (DAPI) (Sigma, Munich, Germany) for
nuclear staining.
The excitation wavelengths and detection ranges used for confocal imaging of live and fixed cells
were as follows: 488 nm and 500–550 nm for EGFP; 575 nm, 588–650 nm for mCherry; and 405 nm
and 430–500 nm for DAPI. The hybrid (HyD) detectors were operated in the gated mode in order to
suppress parasite reflection from the bottom glass surface of the cell-culture dish.
Fluorescence intensity was quantified using the function Measure in ImageJ (Rasband, W.S., U. S.
National Institutes of Health, Bethesda, MD, USA, https://imagej.nih.gov/ij/). Measurements were
performed on 20 non-irradiated and 20 irradiated cells for each time point (15, 30, 45 and 60 min).
3.8. FRET-FLIM Analysis
Fluorescence lifetime measurements were performed with Leica TCS SP8 X FLIM confocal
microscope (Leica Microsystems, Wetzlar, Germany), using the time-correlated single photon counting
(TCSPC) module (PicoQuant, Berlin, Germany). For photon detection, spectral FLIM photomultipliers
(SP) were used. Data analysis was performed using SymPhoTime64 software (PicoQuant, Berlin,
Germany). Photon detection for the entire single cell and the cell cytoplasm was set to 100 repetitions,
and for the cell nuclei to 300 repetitions, with the peak count rate adjusted between 200 and 500 kcounts/s.
The donor fluorophore, EGFP, was excited at 488 nm using a pulsed supercontinuum excitation laser
with the pulse frequency set to 40 MHz. Temperature control and CO2 equilibration were performed
as described above (see live-cell imaging).
To obtain the fluorescence lifetime of the donor-only sample, cells were transiently transfected
with plasmid carrying donor FRET molecule (EGFP protein fused with NME1 or NME2 protein). Donor
fluorescence lifetime, τ0, was then estimated by fitting a mono-exponential model of fluorescence decay:
N(t) = Ae−t/τ0
to experimental decay curves. This value of τ0 served as a fixed parameter in subsequent analysis
of FRET samples. To obtain the fluorescence lifetime of donor in the presence of acceptor, cells were
transiently transfected with various combinations of plasmids encoding either donor EGFP or acceptor
mCherry fused with NME1 or NME2 proteins. For analyzing the donor fluorescence lifetime in FRET
experiments, we used a double-exponential model of fluorescence decay:
N(t) = A1e−t/τ0 + A2e−t/τq ,
where amplitudes A1 and A2 and quenched lifetime τq were free parameters of the fit. The fraction of
donor molecules that experience FRET, DF, was calculated as:
DF = A2/(A1 + A2).
For each pair of fusion proteins, measurements were performed on 20 non-irradiated cells and 24
irradiated cells, DF was determined for each cell, and then averaged (median ± interquartile range).
Statistical comparison between samples was performed using the Kruskal–Wallis test implemented
in MATLAB software (MathWorks, Natick, MA, USA,) (function kruskalwallis). The post-hoc
Tukey–Kramer test was applied for multiple comparisons (function multcompare). The significance
level was set to 5%.
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drafted the manuscript. I.W., N.S., H.Ć., and M.H.B. reviewed and edited the manuscript. All authors discussed
and approved the final manuscript.
Funding: This work has been fully supported by Croatian Science Foundation under the project numbers
IP-2016-06-4021 to MHB and IP-2013-11-1615 to NS.
Acknowledgments: The authors thank Lucija Horvat for her help in live-cell imaging experiments.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
BER Base Excision Repair
APE1 Apurinic/Apyrimidinic Endonuclease 1
NHEJ Non-Homologous End Joining
CMV Cytomegalovirus
DSBR Double-Stranded Break Repair
EBNA 1–3C Epstein–Barr Nuclear Antigen 1–3C
EGFP Enhanced Green Fluorescent Protein
ERβ Estrogen Receptor β
FLIM Fluorescence-Lifetime Imaging Microscopy
FRET Fluorescence Resonance Energy Transfer
ICAP1α Integrin Cytoplasmic Domain-Associated Protein 1α
ER Endoplasmic Reticulum
COP II Coat Protein Complex II
GFAP Glial Fibrillary Acidic Protein
ARF6 ADP-Ribosylation Factor 6
KSR Kinase Suppressor of Ras
MDM2 Mouse Double Minute 2 Homolog
MIF Macrophage Migration Inhibitory Factor
NDP Nucleoside Diphosphate
NDPK Nucleoside Diphosphate Kinase
NER Nucleotide Excision Repair
NES Nuclear Export Signal
NLS Nuclear Localization Signal
NTP Nucleoside Triphosphate
PDGF Platelet-Derived Growth Factor
STRAP Serine/Threonine Kinase Receptor Associated Protein
TRF1 Telomeric Repeat Binding Factor 1
UVR Ultraviolet Radiation
YNK1 Yeast Homolog of NME1
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